We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZIONZ
6526
DELISTED
Zions Bancorporation N.A. Warrants
ZIONZ
$25K ﹤0.01%
1,400
+1,100
+367% +$22.1K
SWIN
6527
DELISTED
Alps/Dorsey Wright Sector Momentum ETF
SWIN
$25K ﹤0.01%
814
+214
+36% +$6.57K
ARCW
6528
DELISTED
ARC Group Worldwide, Inc
ARCW
$25K ﹤0.01%
10,294
-2,243
-18% -$5.22K
ABEO icon
6529
Abeona Therapeutics
ABEO
$388M
$24K ﹤0.01%
60
-6,023
-99% -$2.63M
ACU icon
6530
Acme United Corp
ACU
$211M
$24K ﹤0.01%
+1,133
New +$24.6K
CIF
6531
DELISTED
MFS Intermediate High Income Fund
CIF
$24K ﹤0.01%
9,532
-1,069
-10% -$2.83K
CLPS icon
6532
CLPS Inc
CLPS
$26M
$24K ﹤0.01%
+1,876
New +$15.6K
COE
6533
51Talk Online Education Group
COE
$114M
$24K ﹤0.01%
+559
New +$24.9K
DIVB icon
6534
iShares Core Dividend ETF
DIVB
$1.73B
$24K ﹤0.01%
916
-1,298
-59% -$33.4K
DRV icon
6535
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.4M
$24K ﹤0.01%
50
+9
+22% +$5.3K
ERNA icon
6536
Eterna Therapeutics
ERNA
$4.78M
0
FTXL icon
6537
First Trust Nasdaq Semiconductor ETF
FTXL
$1.42B
$24K ﹤0.01%
+746
New +$24.5K
IRS
6538
IRSA Inversiones y Representaciones
IRS
$1.26B
$24K ﹤0.01%
+1,413
New +$29K
MCRB icon
6539
Seres Therapeutics
MCRB
$49.8M
$24K ﹤0.01%
140
+35
+33% +$5.72K
ONCY
6540
Oncolytics Biotech
ONCY
$95.1M
$24K ﹤0.01%
+4,291
New +$26.4K
SLGL icon
6541
Sol-Gel Technologies
SLGL
$288M
$24K ﹤0.01%
307
+207
+207% +$18.9K
SMDD icon
6542
ProShares UltraPro Short MidCap400
SMDD
$1.95M
$24K ﹤0.01%
+43
New +$25.8K
YXI icon
6543
ProShares Short FTSE China 50 of PROSHARES TRUST
YXI
$4.61M
$24K ﹤0.01%
601
-104
-15% -$3.86K
MIXT
6544
DELISTED
MIX TELEMATICS LIMITED
MIXT
$24K ﹤0.01%
1,342
+1,214
+948% +$21.7K
SURF
6545
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$24K ﹤0.01%
+1,482
New +$21.4K
IDLB
6546
DELISTED
Invesco FTSE International Low Beta Equal Weight ETF
IDLB
$24K ﹤0.01%
821
-43
-5% -$1.31K
RLH
6547
DELISTED
Red Lions Hotel Corporation
RLH
$24K ﹤0.01%
2,037
+308
+18% +$3.27K
EGIF
6548
DELISTED
Eagle Growth and Income Opportunities Fund
EGIF
$24K ﹤0.01%
1,583
-483
-23% -$7.38K
SDRL
6549
DELISTED
Seadrill Limited Common Stock
SDRL
$24K ﹤0.01%
419
-123
-23% -$11.3K
VTIQU
6550
DELISTED
VectoIQ Acquisition Corp. Unit
VTIQU
$24K ﹤0.01%
+2,350
New +$23.6K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.